Borrelia + VlsE IgG Europe

Virotech Borrelia + VlsE IgG Europe (96 tests) - EC024G00

Enzyme-linked immunosorbent assay intended as screening test for the semiquantitative and qualitative detection of IgG antibodies against Borrelia burgdorferi sensu lato in human serum or plasma.

  • Ready-to-use, color-coded reagents and plates, with breakable strips
  • CSF diagnosis possible with additional control sets
  • General components suitable for all kits and lots
  • Same incubation times across parameter
  • Standardized methods suitable for automated procedures
  • CE-IVD

Disease: Lyme diseases

Symptoms: Multisystemic illness. Early manifestations: Erythema migrans; flu- like symptoms like fever, myalgias and headaches; carditis; meningitis. Late manifestations: Chronic neurological, dermatological and / or cardiological symptoms; Acrodermatitis chronica atrophicans; Herxheimer reaction; Lyme-Arthritis

Mechanism of Infection: Transmission by tick bite; Europe: Ixodes ricinus; USA: Ixodes dammini

EC024G00
Product
Order no.
Format
Wishlist
Borrelia + VlsE IgG Europe
Order no.EC024G00
Format96 tests
Add to wishlist

Documents

Name
Document type
Language
Format
Document
Borrelia + VlsE IgG Europe
IFUIFU
Formatpdf
This document is only available for registered users. Login to reach it.
Borrelia + VlsE IgG Europe
BrochureBrochure
Language
Formatpdf
Please select a language version!